We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Hematology Analyzer Evaluated for Reliability and Efficiency

By LabMedica International staff writers
Posted on 10 Dec 2012
A high throughput hematology analyzer is found to be reliable, efficient, as well as highly user-friendly and ergonomically designed. More...


A recently introduced series of hematology analyzers are able to carry out complete blood count (CBC), eight-part differential, reticulocyte and erythroblast analysis, as well as body fluids measurements (CBF).

Hematologists at St-Joseph St-Luc Hospital (Lyon, France) evaluated the Pentra DX Nexus analyzers, which offer 50 parameters and a high throughput of 120 samples per hour. The study used the XE-2100 (Sysmex; Kobe, Japan) as a reference system to compare the functions and ergonomics of the workcell. This consisted of a Pentra DX Nexus analyzer, SPS evolution slide maker/stainer and ABX Pentra ML data management system (HORIBA Medical; Northampton, UK).

The results of the evaluations show the instrument’s performance to be very good and the system offers significant improvements over previous generations of the Pentra analyzers for both traceability and ergonomics. The stability and precision functional evaluation of the results demonstrated that the technical abilities of the analyzer fulfilled stringent medical requirements and the manufacturer’s specifications.

A significant improvement in the new Pentra DX Nexus model is the color touch screen that uses easily identifiable icons to denote different functions of the analyzer. The virtual keyboard was found by the study participants to be more useful than a physical keyboard for entering data. Transferring data and hardware connections have also been made easier by multiple USB ports. In addition, a new laser source dissipates less heat and reduces the power requirements and noise generated by the instrument. The study found that the reduced size of the analyzer was also a positive attribute for laboratories, where space is of a premium.

Cleve Wright, General Manager of HORIBA Medical said, “With its new color touch screen and smart access to various functionalities, the Pentra Nexus is an exciting addition to our broad range of Pentra hematology analyzers. All are designed to meet our many differing customer requirements, both in the laboratory and at the point-of-care.”

Related Links:

St-Joseph St-Luc Hospital
Sysmex
HORIBA Medical



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
HPV Test
Allplex HPV28 Detection
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.